Kroger Reports Modest Sales Growth Amid Pharmacy Pressures in Q2 Earnings
Kroger Co. (NYSE: KR) has reported modest growth in its second-quarter identical sales, with an increase of 0.2% excluding fuel. The company's Chief Executive Officer, Greg Foran, noted that sales were performing well until the final reporting period, when a Cyclospora outbreak adversely affected produce sales, contributing to a reduction in identical sales without fuel by approximately 35 basis points. This outbreak, alongside other factors, has influenced consumer behavior and spending patterns.
In terms of financial performance, Kroger reported adjusted earnings per diluted share of $1.09, reflecting a 5% increase from the same period last year. The adjusted FIFO operating profit stood at $1.1 billion. Chief Financial Officer David Kennerley highlighted several factors that collectively created a 265-basis-point drag on identical sales without fuel during the quarter. These included a 140-basis-point impact from the Inflation Reduction Act, a 60-basis-point effect from customers transitioning from branded to generic prescriptions, a 35-basis-point impact from the Cyclospora outbreak, and a 30-basis-point effect from ongoing egg deflation.
Despite these challenges, Kroger has seen a slight increase in customer traffic, both in-store and online, although the average transaction value has declined as consumers remain cautious with their spending. Factors such as rising fuel prices and reduced SNAP benefits have contributed to this disciplined approach to shopping. Notably, categories such as natural foods, meat and seafood, and bakery items have performed well during this period.
Kroger continues to outperform its competitors, maintaining a market-share advantage over Circana's benchmark of traditional grocery competitors. However, the company has lowered its full-year identical-sales-without-fuel outlook to a range of 0.2% to 0.8%, down from its previous guidance of 1% to 2%. This revision reflects the results from the first half of the year and anticipates ongoing pressures, including the lingering effects of the Cyclospora outbreak in the upcoming third quarter.




